University of Siena Molecular and developmental medicine-Siena, Italy 2017-today
PhD student in Molecular Medicine Expected graduation: 02/2021
University of Florence School of human health sciences-Florence, Italy 2014-2016
Master's degree in Pharmaceutical Biotechnologies
University of Florence School of human health sciences-Florence, Italy 2010-2014
Bachelor’s degree in Medical Biotechnologies
RESEARCH EXPERIENCE
Experimental Cardiology – Academic Medische Centra, Amsterdam, Netherlands 09/18-03/19
Project title: “Effects of mexiletine on the sodium channel overlap syndrome mutation SCN5A-1795insD” Supervisor: S.Casini; C. A. Remme
Department of Pharmacology - University of Florence, Florence, Italy 02/2016-07/2016
Project title: “The efficacy of Late Sodium channel blockers in hypertrophic cardiomiopaty depends from genotype: a study on transgenic mouse model with different mutation” Supervisor: R. Coppini; E. Cerbai
PUBLICATIONS:
Title: “Late sodium current inhibitors to treat exercise-induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium.” Ferrantini C, Pioner JM, Mazzoni L, Gentile F, Tosi B, Rossi A, Belardinelli L, Tesi C, Palandri C, Matucci R, Cerbai E, Olivotto I, Poggesi C, Mugelli A, Coppini R. British journal of pharmacology 2018 July
POSTERS AND CONGRESS:
EHRA congress working group in cellular electrophysiology - LISBON - February 2019
Poster Title: “Effects of mexiletine on the sodium channel overlap syndrome mutation SCN5A-1795insD”
FCVB: Frontiers in Cardiovascular Biology congress - VIENNA - April 2018
Poster Title: “Electrophysiological characterization of induced pluripotent stem cell derived cardiomyocytes from Douchenne Muscular Dystrophy”
SIRC: XXI congresso nazionale Società Italiana Di Ricerche Cardiovascolari – IMOLA – November 2017
Poster Title: “The efficacy of Late Sodium channel blockers in hypertrophic cardiomiopaty depends from genotype: a study on transgenic mouse model with different mutation”
